Infectious Disease Clinical Development Expertise

Infectious diseases and other emerging health challenges are a threat
everywhere – not just in low-income and non-western countries. Time is of the essence when it comes to infectious disease treatments, especially as antibiotics become less effective and as new viral strains appear.

Veristat is committed to helping clients advance their life-saving treatments and prevention of life-threatening infectious diseases.   Veristat teams have conducted more than 160 Infectious Disease programs for drugs, biologics and vaccines.

Experience Battling Infectious Diseases

Whether you are aiming to prevent or combat a viral, bacterial, fungal or parasitic infection, Veristat can help make the difference for your study’s success. Our teams understand the nuances and difficulties involved with treating infectious diseases, have the experience to perform vaccine trials, and are adept with rapid response to global pandemics that arise.
infectious_disease_stats

Explore Our Recent Infectious Disease Experience

 

infectious_disease_experience_table

 

Learn More with These Resources

Case Study

Supporting Global Approval of a First-in-ClassGene Therapy ...

Learn how Veristat coordinated clinical operations to support U.S. and EU approval of a rare disease gene therapy.

DOWNLOAD

Infographic

A Practical Guide for Managing Multiple Global Regulatory ...

This infographic outlines a seven-step frame work to plan, coordinator, and delivery successful global simultaneous regulatory submissions.

DOWNLOAD

Infographic

FDA Expedited Programs – What You Need to Know

This infographic highlights FDA’s expedited pathways, summarizing key benefits, criteria, and timing for faster development and approval of therapies for serious conditions.

Download
Request A Proposal
  • Privacy Policy

  • ©2023 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.